DJIA 17,830.63 18.44 0.10%
NASDAQ 5,112.00 9.20 0.18%
S&P 500 2,090.70 1.56 0.07%
market minute promo

Roche Holding Ltd. (ADR) (NASDAQOTH: RHHBY)

33.22 0.32 (0.97%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

RHHBY $33.22 0.97%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.38
Previous Close $32.90
Daily Range $33.27 - $33.43
52-Week Range $31.50 - $38.54
Market Cap $186.7B
P/E Ratio 0.00
Dividend (Yield) $0.00 (2.5%)
Volume 261,903
Average Daily Volume 1,215,756
Current FY EPS $1.82





Roche Holding Ltd. (ADR) (RHHBY) Description


News & Commentary Rss Feed

Why Celldex Therapeutics Shares Jumped Today

Positive new data for a promising new treatment for brain cancer could help clear the way to a new standard of care.

Did You Miss These Top Stories in Healthcare?

Last week's most exciting healthcare news: Exelixis nets a win, and Colorado takes aim at health insurers.

6 Stocks That Could Double In 2016

If you have some extra cash and want to take a chance, these six stocks have the potential for excellent returns.

5 Reasons Roche Thinks It Can Outclass the Competition

With five compounds unchallenged in their class, Roche has one of the industry's most exciting late-stage pipelines.

Why Exelixis Shares Declined Today

Financial results trump the FDA approval of a key new drug.

Why Halozyme Therapeutics Inc Is Heading Lower Today

An increase in spending caused results to come up a bit short of expectations, but the long term story appears to be on track.

3 Biotech Stocks to Buy in November

Our Motley Fool contributors think that these 3 biotech stocks are great buys right now.

5 Healthcare Trends to Invest in for the Next 20 Years

Our contributors think that healthcare-focused investors should watch these 5 long-term healthcare trends.

Why Pacific Biosciences of California Jumped Today

The sequencer maker scales the wall of worry created by its competitor.

Did Roche Unleash Biogen's Worst Nightmare?

Roche's once-failed rheumatoid arthritis therapy hit a bullseye in relapsing multiple sclerosis.

See More RHHBY News...

RHHBY's Top Competitors

RHHBY $33.22 (0.97%)
Current stock: RHHBY
JNJ $102.21 (0.16%)
Current stock: JNJ
NVS $86.44 (0.05%)
Current stock: NVS
GSK $40.80 (1.02%)
Current stock: GSK